Key facts
- GATC Health’s last known valuation is $525.0M (Sep 2025).
- It has raised $55.2M across 5 recorded rounds; the latest was Seed Round ($621K) in Aug 2023.
- Notable investors include West Virginia Jobs Investment Trust Board.
- GATC Health has filed 13 Form Ds with the SEC since 2020, most recently Sep 2025 ($26.0M sold to 251 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for GATC Health
Funding rounds
5 roundsAbout GATC Health
Developer of a technology-driven bioinformatics platform designed to support drug discovery and development. The company offers proprietary artificial intelligence models and data-driven molecular analysis, enabling biopharmaceutical companies and investors to improve the assessment of drug safety and effectiveness during research and development.
- Sector
- Healthcare
- HQ
- Irvine, CA, United States
- Founded
- 2020
- Employees
- 46
- Website
- gatchealth.com/
- Ownership
- Privately Held (backing)
GATC Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GATC Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GATC Health in its N-PORT filings yet. We sweep new filings monthly.